Biodesix & New Approaches to Comprehensive Molecular Testing: Focus on Accurate Results with Rapid Turn-around, High-throughput and Low Sample Requirements for Diagnosis and Monitoring
Recent advances in laboratory testing have been focused on molecular readouts as key technologies. Biodesix assembled a panel of subject matter experts, from both academia and industry, who will share clinically relevant studies to demonstrate how advances in turn-around time to results, increased throughput, and maximized sample use are driving new test development and utility in the laboratory. Our focus will be on newer approaches integrating NGS, ddPCR, and Mass Spectrometry. Studies will include clinical diagnostic utility, as well as advanced research concepts in monitoring therapeutic response.
